Science 37
OverviewSuggest Edit
Science 37 is a mobile technology and clinical trials organization. The company is focused on the development of networked patient-centric models for clinical research to rapidly accelerate biomedical discovery. Science 37 leverages partnerships with national mobile nursing companies, pharmacy chains, patient advocacy groups, virtual e-consenting, mobile devices, and other technology companies to maximize efficiency. Then, using design-thinking principles and rapid prototyping Science 37 puts patients first and brings clinical trials right to their homes.
| Type | Private | |
| Founded | 2014 | |
| HQ | Los Angeles, US | Map |
| Website | science37.com | |
| Employee Ratings | More |
Latest Updates
| Employees (est.) (Sept 2020) | 222 | (+11%) |
| Cybersecurity rating | C | More |
Key People/Management at Science 37
Noah Craft
CEO
Science 37 Office Locations
Science 37 has an office in Los Angeles
Los Angeles, US (HQ)
12121 Bluff Creek Dr #100, Playa Vista
Science 37 Financials and Metrics
Summary Metrics
Founding Date | 2014 |
Science 37 total Funding | $106.5 m |
Science 37 latest funding size | $40 m |
Time since last funding | a month ago |
Science 37 investors | Glynn Capital Management, Lux Capital, Novartis, Redmile Group, Amgen, Amgen Ventures, Sanofi-Genzyme BioVentures, dRx Capital, GV, Mubadala Ventures, Sanofi Ventures, PPD, LifeSci Ventures |
Science 37's latest funding round in August 2020 was reported to be $40 m. In total, Science 37 has raised $106.5 m
Science 37 Cybersecurity Score
Science 37 Online and Social Media Presence
371 Twitter followers
Science 37 has 371 Twitter Followers. The number of followers has decreased 0.3% month over month and decreased 0.6% quarter over quarter
Science 37's Trends
Science 37 News and Updates
August 20, 2020
Science 37, a virtual trials startup once eyed by Alphabet's Verily, just raised $40 million to push the drug industry decades into the future
Science 37 just raised $40 million for its online approach to drug research.
Coronavirus sent new business its way, as outbreaks shut down hospitals that normally run trials.
Now, the startup is fielding new business from top drugmakers and plans to expand around the world.
It also caught the att…
Science 37 Blogs
March 12, 2020
Navigating Clinical Trials in the Coronavirus Era
The report explores approaches for sponsors to mitigate risks to patient safety and business continuity in clinical trials—both immediately and moving forward. LOS ANGELES, March 12, 2020 — Science 37, the industry leader in decentralized clinical trials, today published a report examining key con…
January 14, 2020
Science 37 ® Extends Market-Leading Capabilities in Decentralized Clinical Trial Execution
New additions to the Science 37 executive team will enhance both the patient and sponsor experiences as well as extend patient recruitment and trial execution efficiencies LOS ANGELES, January 14, 2020 — Science 37, the industry leader in decentralized clinical trials, recently announced that Jonat…
November 21, 2019
Science 37® Names David Coman Chief Executive Officer
Organization extends its market leadership in the decentralized clinical trial industry LOS ANGELES, November 21, 2019 — Science 37, the industry leader in decentralized clinical trials, announced today that David Coman has joined the company as its chief executive officer. Coman joins Science 37 fr…
March 05, 2019
Science 37 Raises $35M in Funding to Continue to Drive Growth – Announces Leadership Transition
Ingelheim, Germany and Playa Vista, CA, USA , January 3, 2019 - Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced today a technology enterprise collaboration agreement that will support Boehringer Ingelheim in running remote clinical trials. Science 37 is …
February 25, 2019
Siteless Clinical Trials Are Changing the Game for Patients
The completion of Science 37’s first siteless clinical trial demonstrates that this kind of study can actually work, and it can work well for all involved.
The post Siteless Clinical Trials Are Changing the Game for Patients appeared first on Trial Mix.
January 03, 2019
Science 37 and Boehringer Ingelheim Initiate a Collaborative Partnership to Accelerate Patient Centricity in the Development of Novel Therapies
Ingelheim, Germany and Playa Vista, CA, USA , January 3, 2019 - Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced today a technology enterprise collaboration agreement that will support Boehringer Ingelheim in running remote clinical trials. Science 37 is …
Science 37 Frequently Asked Questions
When was Science 37 founded?
Science 37 was founded in 2014.
Who are Science 37 key executives?
Science 37's key executives are Noah Craft.
How many employees does Science 37 have?
Science 37 has 222 employees.
Who are Science 37 competitors?
Competitors of Science 37 include Entale, Driftscape and Yttro Mobile.
Where is Science 37 headquarters?
Science 37 headquarters is located at 12121 Bluff Creek Dr #100, Playa Vista, Los Angeles.
Where are Science 37 offices?
Science 37 has an office in Los Angeles.
How many offices does Science 37 have?
Science 37 has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies